Peripheral CT indices address risk for fracture contributed by changes in bone microarchitecture

Report provides guidance on reducing CV risk in patients with T2DM and atherosclerotic CV disease

Breastfeeding lowers risk in those large for gestational age, but only without maternal diabetes

Last week, I got a new update of software for my Stages power meter. The Stages is a device that is milled into the left crank arm (what the pedal is screwed into) of my bike. This device measures the power (as wattage) that I create when I am on …

Man, 69 years of age, of Italian descent, “a numbers guy,” has type 2 diabetes, A1C 8.9%, taking a GLP-1 daily, and metformin 1,000mg twice daily. Blood pressure was managed, in target range of ~110-120/70-80, HR 76-82, weight-BMI 25.3. Had been on an SGLT-2, but developed DKA, so he can no longer take SGLT-2’s nor did he want to. Checked fasting glucose some mornings a week but not every day because he did not like to stick his finger. He really didn’t want to deal with his diabetes. Due to his recent illness, he was willing to try something new and different, especially since I told him it’s about numbers and he would not have to regularly stick his fingers.

Judith Wylie-Rosett, EdD, RD, is a professor at the Albert Einstein Medical Center and co-director of the New York Regional Center for Diabetes Translation Research in Bronx, NY. Dr. Wylie-Rosett’s research focuses on nutrition’s role in preventing and controlling chronic diseases—particularly diseases such as type 2 diabetes and heart disease in which obesity is an important risk factor.  She is associate editor of the journal Diabetes Care and author of The Complete Weight Loss Workbook. Dr. Wylie-Rosett has helped the American Diabetes Association and American Heart Association develop nutrition-related recommendations and position statements.

In this week's Homerun Slides, the conclusion of comparing Flash CGM with Dexcom rtCGM.

Glucokinase MODY: Glucokinase catalyzes the phosphorylation of glucose to glucose-6-phosphate. Its unique kinetic properties result in the rate of glucose phosphorylation being proportional to the physiologic glucose concentration. This means that the beta cell and hepatocyte can respond appropriately to fluctuations in the degree of glycemia. In the pancreatic beta cell, glucokinase acts as “the glucose sensor” ensuring insulin release is appropriate to the blood glucose concentration.

In this Exclusive Interview transcript, Judith Wylie-Rosett talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about non-nutritive sweetener safety and uses, and the effect of low-calorie, sweetened beverages on cardiometabolic health.

In this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about the use of low-calorie, sweetened beverages on cardiometabolic health.